What is Colleen Reisz's NPI number?

Colleen Reisz's National Provider Identifier (NPI) is 1720054364, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Colleen Reisz's specialty?

Colleen Reisz is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Colleen Reisz located?

Colleen Reisz's practice location on file with NPPES is 5330 N Oak Trfy, Kansas City, MO 64118-4699.

What is Colleen Reisz's phone number?

The practice phone number listed in the NPPES registry for Colleen Reisz is (816) 454-0666.

Does Colleen Reisz accept Medicare?

Colleen Reisz is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Colleen Reisz's NPI active?

Yes — Colleen Reisz's NPI (1720054364) is active in the NPPES registry as of the last update on 2023-05-15.

IndividualActiveAccepts Medicare

Colleen Reisz, MD

NPI 1720054364 · Dermatology Physician · Kansas City, MO

Colleen Reisz, MD is a Dermatology Physician provider in Kansas City, MO (NPI 1720054364).

Provider details

NPI number: 1720054364
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: No
License: 105404 (MO)

Practice location

5330 N Oak Trfy

Ste 201

Kansas City, MO 64118-4699

Phone: (816) 454-0666

Fax: (816) 559-7118

Street-level locationGet directions

More MO providers

Mailing address

5330 N Oak Trfy

Kansas City, MO 64118-4699

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 105404 (MO)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(76/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,969 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	586	$124
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	283	$87
Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215	172	$175
Destruction of Precancer Skin Growth, 2-14 Growths17003	169	$6
Biopsy of Related Skin Growth, First Growth11102	145	$89
Destruction of Skin Growth, 1-14 Growths

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 35 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	212	99
Methotrexate Sodiumbrand: Methotrexate	98	24
Pantoprazole Sodium	98	31
Betamethasone Dipropionate	97	47
Mometasone Furoate	84	43
Hydroxychloroquine Sulfate	79	18
Ketoconazole	68	39

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$907 across 31 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-02-24
Last updated: 2023-05-15
Certified: 2023-05-15

Frequently asked questions

What is Colleen Reisz's NPI number?: Colleen Reisz's National Provider Identifier (NPI) is 1720054364, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Colleen Reisz's specialty?: Colleen Reisz is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Colleen Reisz located?: Colleen Reisz's practice location on file with NPPES is 5330 N Oak Trfy, Kansas City, MO 64118-4699.
What is Colleen Reisz's phone number?: The practice phone number listed in the NPPES registry for Colleen Reisz is (816) 454-0666.
Does Colleen Reisz accept Medicare?: Colleen Reisz is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Colleen Reisz's NPI active?: Yes — Colleen Reisz's NPI (1720054364) is active in the NPPES registry as of the last update on 2023-05-15.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	586	$124
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	283	$87
Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215	172	$175
Destruction of Precancer Skin Growth, 2-14 Growths17003	169	$6
Biopsy of Related Skin Growth, First Growth11102	145	$89
Destruction of Skin Growth, 1-14 Growths

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 35 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	212	99
Methotrexate Sodiumbrand: Methotrexate	98	24
Pantoprazole Sodium	98	31
Betamethasone Dipropionate	97	47
Mometasone Furoate	84	43
Hydroxychloroquine Sulfate	79	18
Ketoconazole	68	39

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$907 across 31 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments